3
Scienture Holdings, Inc. (NASDAQ:SCNX) stock is trading higher on Thursday after the company partnered with Kindeva to launch REZENOPY.
What To Know: Under the agreement, Kindeva will manufacture and supply the REZENOPY nasal spray, an opioid overdose treatment. Scienture will own the new drug application and handle sales, marketing and …